Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan

Simple item page
dc.contributor.authorYelekenova, A.
dc.contributor.authorBektur, C.
dc.contributor.authorNurgozhin, T.
dc.date.accessioned2015-11-05T09:42:49Z
dc.date.available2015-11-05T09:42:49Z
dc.date.issued2014
dc.description.abstractThis study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of Kazakhstan.ru_RU
dc.identifier.isbn9786018046728
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/794
dc.language.isoenru_RU
dc.publisherNazarbayev Universityru_RU
dc.subjectpharmacoeconomicru_RU
dc.subjectanalysisru_RU
dc.subjectdiabetesru_RU
dc.subjectmetforminru_RU
dc.subjecttherapyru_RU
dc.titlePharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstanru_RU
dc.typeAbstractru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
P H A R M A C O E C O N O M I C.pdf
Size:
86.07 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

NU Research Week - II